skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
Material Type:
Artigo
Adicionar ao Meu Espaço

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

LU, Karen H ; WOOD, Marie E ; RUBINSTEIN, Wendy S ; STOFFEL, Elena M ; SNYDER, Carrie ; SYNGAL, Sapna ; MERRILL, Janette K ; WOLLINS, Dana Swartzberg ; HUGHES, Kevin S ; DANIELS, Molly ; BURKE, Cathy ; FORD, James ; KAUFF, Noah D ; KOHLMANN, Wendy ; LINDOR, Noralane M ; MULVEY, Therese M ; ROBINSON, Linda

Journal of clinical oncology, 2014-03, Vol.32 (8), p.833-840 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

2
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F

Damodaran, Senthil ; Zhao, Fengmin ; Deming, Dustin A ; Mitchell, Edith P ; Wright, John J ; Gray, Robert J ; Wang, Victoria ; McShane, Lisa M ; Rubinstein, Larry V ; Patton, David R ; Williams, P Mickey ; Hamilton, Stanley R ; Suga, Jennifer M ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay N ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith T

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1552-1561 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

3
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

Chae, Young K ; Hong, Fangxin ; Vaklavas, Christos ; Cheng, Heather H ; Hammerman, Peter ; Mitchell, Edith P ; Zwiebel, James A ; Ivy, S Percy ; Gray, Robert J ; Li, Shuli ; McShane, Lisa M ; Rubinstein, Larry V ; Patton, David ; Williams, P Mickey ; Hamilton, Stanley R ; Mansfield, Aaron ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay N ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith T

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2407-2417 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

4
Deep learning tumor heterogeneity metric from histopathology images vs next generation sequencing-derived scores for colon cancer prognostication
Material Type:
Artigo
Adicionar ao Meu Espaço

Deep learning tumor heterogeneity metric from histopathology images vs next generation sequencing-derived scores for colon cancer prognostication

Amiji, Hatim ; Sheridan, Todd Brinsley ; Chuang, Jeffrey ; Rubinstein, Jill Carol

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3537-3537 [Periódico revisado por pares]

Texto completo disponível

5
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Azad, Nilofer S ; Gray, Robert J ; Overman, Michael J ; Schoenfeld, Jonathan D ; Mitchell, Edith P ; Zwiebel, James A ; Sharon, Elad ; Streicher, Howard ; Li, Shuli ; McShane, Lisa M ; Rubinstein, Larry ; Patton, David R ; Williams, P Mickey ; Coffey, Brent ; Hamilton, Stanley R ; Bahary, Nathan ; Suga, J Marie ; Hatoum, Hassan ; Abrams, Jeffrey S ; Conley, Barbara A ; Arteaga, Carlos L ; Harris, Lyndsay ; O'Dwyer, Peter J ; Chen, Alice P ; Flaherty, Keith T

Journal of clinical oncology, 2020-01, Vol.38 (3), p.214-222 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

6
Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?
Material Type:
Artigo
Adicionar ao Meu Espaço

Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

DODD, Lori E ; KORN, Edward L ; FREIDLIN, Boris ; JAFFE, C. Carl ; RUBINSTEIN, Lawrence V ; DANCEY, Janet ; MOONEY, Margaret M

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3791-3796 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

7
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
Material Type:
Artigo
Adicionar ao Meu Espaço

Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute

Chihara, Dai ; Huang, Erich P ; Finnigan, Shanda R ; Cordes, Lisa M ; Skorupan, Nebojsa ; Fukuda, Yoko ; Rubinstein, Larry V ; Ivy, S Percy ; Doroshow, James H ; Nastoupil, Loretta J ; Flowers, Christopher R ; Takebe, Naoko

Journal of clinical oncology, 2022-06, Vol.40 (17), p.1949-1957 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

8
Targeting cell-bound MUC1 on myelomonocytic leukemias and leukemic stem cells: Therapeutic implications
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting cell-bound MUC1 on myelomonocytic leukemias and leukemic stem cells: Therapeutic implications

Rubinstein, Daniel B. ; Guillaume, Thierry

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14003-e14003 [Periódico revisado por pares]

Texto completo disponível

9
Markers of immune checkpoint inhibitor efficacy in the AACR Project GENIE database
Material Type:
Artigo
Adicionar ao Meu Espaço

Markers of immune checkpoint inhibitor efficacy in the AACR Project GENIE database

Yang, Yuanchu J ; Rubinstein, Sam ; Warner, Jeremy Lyle

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15091-e15091 [Periódico revisado por pares]

Texto completo disponível

10
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

KUMMAR, Shivaani ; KINDERS, Robert ; MURGO, Anthony J ; COLLINS, Jerry ; STEINBERG, Seth M ; ELIOPOULOS, Helen ; GIRANDA, Vincent L ; GORDON, Gary ; HELMAN, Lee ; WILTROUT, Robert ; TOMASZEWSKI, Joseph E ; DOROSHOW, James H ; GUTIERREZ, Martin E ; RUBINSTEIN, Larry ; PARCHMENT, Ralph E ; PHILLIPS, Lawrence R ; JIUPING JI ; MONKS, Anne ; LOW, Jennifer A ; CHEN, Alice

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2705-2711 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Resultados 1 2 3 4 5 next page

Buscando em bases de dados remotas. Favor aguardar.